← Evidence map

TrialNaunyn-Schmiedeberg's archives of pharmacology2026

Bioequivalence assessment of imeglimin hydrochloride tablet, a novel glimin-class antidiabetic agent.

Mamdouh R Rezk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41291275